Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1

Status unconfirmed · Phase 1

Conditions studied: Amphetamine-Related Disorders

In brief

The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral selegiline.

Key facts

Study ID

NCT00033072

Run by

National Institute on Drug Abuse (NIDA)

People needed

16

Starts

2001-09-01

Expected to finish

2002-10-01

Last updated by the study team

2017-01-11

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Volunteers who meet DSM-4 criteria for methamphetamine abuse or dependence; non-treatment seeking individuals
• Be able to verbalize understanding of consent form; provide written informed consent

You may not qualify if…

• Please contact site for more information

Where it is running

• UCLA Integrated Substance Abuse Program — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.